Page 124 - Memoria SEHH 2022

MEMORIA ANUAL 2022 SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
GESMD
FUNDACIÓN ESPAÑOLA DE HEMATOLOGÍA Y HEMOTERAPIA
Bueno C, Barrera S, Bataller A, Ortiz-Maldonado V, Elliot N, O’Byrne S, Wang G, Rovira M, Gutiérrez-Agüera F, Trincado JL, González-González M, Morgades M, Sorigué M, Bárce- na P, Zanetti SR, Torrebadell M, Vega-García N, Rives S, Mallo M, Solé F, Mead AJ, Roberts I, Thongjuea S, Psaila B, Juan M, Delgado J, Urbano-Ispizúa A, Ribera JM, Orfao A, Roy A, Menéndez P .
• Guiding the global evolution of cytogenetic testing for hematologic malignancies. Blood. 2022 Apr 14;139(15):2273-84. doi: 10.1182/blood.2021014309.
Akkari YMN, Baughn LB, Dubuc AM, Smith AC, Mallo M, Dal Cin P, Diez Campelo M, Ga- llego MS, Granada Font I, Haase DT, Schlegelberger B, Slavutsky I, Mecucci C, Levine RL, Hasserjian RP, Solé F, Levy B, Xu X .
• Response to azacitidine in patients with chronic myelomonocytic leukemia accord- ing to overlap myelodysplastic/myeloproliferative neoplasms criteria.
Leuk Res. 2022 May;116:106836. doi: 10.1016/j.leukres.2022.106836.
Triguero A, Xicoy B, Zamora L, Jiménez MJ, García O, Calabuig M, Díaz-Beyá M, Arzuaga J, Ramos F, Medina A, Bernal T, Talarn C, Coll R, Collado R, Chen TH, Borrás J, Brunet S, Marchante I, Marco V, López-Cadenas F, Calbacho M, Simiele A, Cortés M, Cedena MT, Pedreño M, Aguilar C, Pedró C, Fernández M, Stoica C, Ribera JM, Sanz G .
• Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum.
Blood Adv. 2022 Jul 12;6(13):3921-31. doi: 10.1182/bloodadvances.2022007359.
Calvo X, Román-Bravo D, García-Gisbert N, Rodríguez-Sevilla JJ, García-Ávila S, Florensa L, Gibert J, Fernández-Rodríguez C, Salido M, Puiggrós A, Espinet B, Colomo L, Bellosillo B, Ferrer A, Arenillas L .
Comunicaciones orales
Congresos internacionales
• Supervised Machine Learning Improves Risk Stratification in Newly Diagnosed My- elodysplastic Syndromes: An Analysis of the Spanish Group of Myelodysplastic Syn- dromes.
64th American Society of Hematology (ASH) Annual Meeting and Exposition. New Orleans (USA), 10-13 de diciembre de 2022.
124